/

Società

Hi

Non verificato

Hims & Hers

Di cosa scriviamo

FarmaceuticaFitnessSaluteSanitàVetrine/Shopping

51 comunicati stampa

Guarda tutti i comunicati

09/03/2026

Fitness

Accessori

Sanità

Farmaceutica

Vetrine/Shopping

Salute

Pubblico Esercizio/Vendita al dettaglio

Hims & Hers Announces Strategic Shift for US Weight Loss Business

Fonte

Emittente

1.00

0

23/02/2026

Web e Social Network

Telefonia e Varie

Mercato azionario

Farmaceutica

Fitness

Salute

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Fonte

Emittente

1.00

0

19/02/2026

Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

Fonte

Emittente

1.00

0

05/02/2026

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

Fonte

Emittente

1.00

0

04/02/2026

Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care

Fonte

Emittente

1.00

0

02/02/2026

Vetrine/Shopping

Salute

Farmaceutica

Mercato azionario

Eventi

Finanza

Web e Social Network

Telefonia e Varie

Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

Fonte

Emittente

1.00

0

29/01/2026

Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over

Fonte

Emittente

1.00

0

10/12/2025

Hims & Hers Brings Comprehensive Weight Loss Programme to the UK

Fonte

Emittente

1.00

0

04/12/2025

Hims & Hers Now Serving Customers in Canada

Fonte

Emittente

1.00

0

04/12/2025

Hims & Hers Continues Major International Expansion With Official Entry Into Canada

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0